Insulin Pump

Adults with type 1 diabetes who used an automated insulin delivery system with settings changed by the system instead of a provider had improvements in time in range and HbA1c at 13 weeks, according to a speaker.

Young children with type 1 diabetes who used an advanced hybrid closed-loop insulin delivery system had a reduction in HbA1c and improvement in time in range from baseline to 12 weeks, according to study data.

Most health care providers working in hospitals said glycemic control is important to monitor in a hospital setting, but many do not know their institution’s policies regarding the use of diabetes technology, according to survey findings.

The FDA has issued an alert warning people with diabetes using a Medtronic MiniMed 630G or MiniMed 670G insulin pump of a possible cybersecurity risk, according to an agency press release.

BALTIMORE — Providers should practice a patient-centered approach when caring for young children with type 1 diabetes and prepare tips for coping with unique challenges, according to two presenters.

BALTIMORE — In this video exclusive, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, about choosing the right devices and technology for individuals living with diabetes.

BALTIMORE — Multiple patient- and provider-driven barriers may contribute to racial disparities in diabetes device use by children with type 1 diabetes, according to a presenter.

Use of a hybrid closed-loop insulin delivery system provided greater independence and flexibility with glycemic management for young people with type 1 diabetes, according to study findings published in Diabetic Medicine.

Use of continuous glucose monitoring for glycemic management and inpatient diabetes education before discharge may improve outcomes for hospitalized adults with diabetes at risk for hyperglycemia, according to clinical practice guidelines.

A small cohort of pregnant women with type 1 diabetes improved time in range with use of a closed-loop insulin delivery system with a zone model predictive control algorithm, according to findings from a small pilot study.